A Single-Dose, Open-Label, Randomized, Four-Way Crossover Study to Assess the Dose-Proportionality of the Pharmacokinetics of Tapentadol, Given as Tamper-Resistant Tablets, in Healthy Japanese and Korean Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 30 Jan 2014
At a glance
- Drugs Tapentadol (Primary)
- Indications Back pain; Cancer pain; Diabetic neuropathies; Musculoskeletal pain; Neuropathic pain; Pain; Postoperative pain
- Focus Pharmacokinetics
- 04 Nov 2011 Actual initiation date changed from Mar 2011 to Feb 2011 as reported by ClinicalTrials.gov.
- 16 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Apr 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.